Immunotherapy for Renal Cell Carcinoma
Immunotherapy plays a significant role in the management of renal cell carcinoma (RCC) patients with metastatic disease because RCC is highly resistant to both chemotherapy and radiation therapy. Many reports illustrate various approaches to the treatment of RCC, such as cytokine-, antigen- or dendr...
Main Authors: | Momoe Itsumi, Katsunori Tatsugami |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/284581 |
Similar Items
-
Immunotherapy in Renal Cell Carcinoma: The Future Is Now
by: Antoine Deleuze, et al.
Published: (2020-04-01) -
The role of rational immunotherapy for renal cell carcinoma
by: Salma Svetlana
Published: (2003-01-01) -
Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01) -
The use of immunotherapy for metastatic renal cell carcinoma
by: L. Goeman, et al.
Published: (2020-02-01) -
NK Cell-Based Immunotherapy in Renal Cell Carcinoma
by: Iñigo Terrén, et al.
Published: (2020-01-01)